Lazard Healthcare Trigger: Porges Hire

โœ… Lazard hires Geoffrey Porges for its Healthcare Advisory Group. Pipeline alert: Biopharma M&A deal flow is heating up. Next touch: Leverage this trigger to boost your quota and commission.

Published on


Do not index
Do not index

๐Ÿš€ Battle Card: Lazard

Quick trigger:
ย 
๐Ÿ‘ค Decision Maker in the News
ย 
๐Ÿ’ก Why It Matters
  • Deepens biopharma strategic advisory bench just as healthcare deal activity heats up. โ†’ Source
ย 
๐ŸŽฏ Core Pain Point
  • Navigating complex biopharmaceutical M&A and capital strategies
  • Translating scientific innovation into resilient growth plans in volatile markets
ย 
๐Ÿ’ฐ What to Pitch
  • Primary: Strategic M&A Advisory โ†’ Maximize deal value & strengthen competitive positioning
  • Expansion: Capital Markets Solutions โ†’ Optimize funding and risk management for healthcare clients
ย 
๐Ÿ—บ๏ธ Quick Context
  • HQ: New York, NY
  • Employees: โ‰ˆ 3,000
  • Rev: โ‰ˆ $3.5 B
ย 

๐Ÿคผ Competitive Intel

Which other vendors youโ€™ll face to win deals with Lazard across your in-market needs:
ย 
Sales
  • Salesforce (salesforce.com) โ€” Enterprise CRM; robust pipeline analytics.
  • HubSpot (hubspot.com) โ€” Inbound marketing + CRM; SMB-friendly.
  • Outreach (outreach.io) โ€” Sales engagement; cadence automation.
ย 
Ops & Supply Chain
  • SAP Ariba (ariba.com) โ€” Procure-to-pay; global supplier network.
  • Coupa (coupa.com) โ€” Spend management; real-time visibility.
  • Oracle SCM Cloud (oracle.com/scm) โ€” End-to-end supply chain integration.
ย 
HR & People
  • Workday (workday.com) โ€” HCM & finance; unified employee insights.
  • ADP (adp.com) โ€” Payroll & HR services; compliance expertise.
  • BambooHR (bamboohr.com) โ€” User-friendly HRIS; performance tracking.
ย 

โœ… Do-Now Checklist

Connect with Geoffrey Porges on LinkedIn (link above)
Craft first-touch email referencing this Lazard sales trigger
Schedule follow-ups in CRM (Day 3 & Day 10)
ย 

Next Step

Use this Lazard sales trigger to open doors in healthcare advisory. Donโ€™t waitโ€”every Lazard sales trigger is a high-value entry point. Subscribe to NewsletterForLeads
ย 

๐Ÿง  Copy My Prompt for Personalized Cold Outreach

โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€
โœ๏ธ YOUR COMPANY
โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€
OUR_COMPANY   = โ‘โ‘
OFFER_BRIEF   = โ‘AI-driven M&A strategy platformโ‘
PROOF_METRIC  = โ‘reduced deal cycles by 30%โ‘
CTA_STYLE     = โ‘quick_callโ‘
TONE          = โ‘punchyโ‘

โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€
๐Ÿ“Œ TARGET COMPANY
โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€
NAME        = Geoffrey
COMPANY     = Lazard
DEPT        = Healthcare Advisory Group
SIZE        = โ‰ˆ 30
BOTTLENECK  = lack of specialized biopharma advisory capacity
EVENT       = Hires Geoffrey Porges to Healthcare Advisory Group
DETAIL      = Dr. Geoffrey Porges joining as MD
PAIN        = Navigating complex biopharmaceutical M&A and capital strategies
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250918506743&div=41152219
SIM_CO      = Evercore
WIN_METRIC  = โ‰ˆ 25% faster deal closings
NEXT_SIZE   = โ‰ˆ 50
EMP_EST     = โ‰ˆ 3,000
REV_EST     = โ‰ˆ $3.5 B

โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€
TASK FOR CHATGPT
โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€
Role: โ€œNewsletterForLeads SDR-Assistโ€.

Validate any โ‰ˆ guesses via SRC.

EMAIL  (keep breaks):
Subject: โ‰ˆ 30-person Healthcare Advisory Group

Geoffreyโ€”noticed your Healthcare Advisory Group team is โ‰ˆ 30.

Thatโ€™s when lack of specialized biopharma advisory capacity slows growth.

We helped Evercore fix this with AI-driven M&A strategy platform.

Result: โ‰ˆ 25% faster deal closings.  
Quick call?

PSโ€”next bottleneck hits โ‰ˆ 50.

DM โ‰ค45 words, TONE:
Saw your post about Dr. Geoffrey Porges joining as MD โ€” Navigating complex biopharmaceutical M&A and capital strategies.  
AI-driven M&A strategy platform. reduced deal cycles by 30%.  
Quick chat?

Join other 3200+ marketers now!

Ready to take the next big step for your business?

Subscribe